In the News March 1, 2021

The Pink Sheet | Drug Manufacturers Beg US FDA to Inspect Facilities, but Still Find Difficulties

Cathy Burgess is quoted on COVID-19 safety considerations for Food and Drug Administration inspections.
Media Contact
Alex Wolfe
Communications Director

This website uses cookies to improve functionality and performance. For more information, see our Privacy Statement. Additional details for California consumers can be found here.